NFGC - Supported Publications from 2006 Shin H, Sampat M, Bish SF, Koomen JM, Markey MK. Statistical Characterization of Chemical Noise in MALDI TOF MS by Wavelet Analysis of Multiple Noise Realizations. AMIA Annu Symp Proc. 2006; 1092. PMID: 17238711 (Proteomics Core). Turner JG, Gump JL, Zhang C, Cook JM, Marchion D, Hazlehurst L, Munster P, Schell MJ, Dalton WS, Sullivan DM. ABCG2 expression, function and promoter methylation in human multiple myeloma. Blood. 2006 Dec 1; 108(12):3881-9. Epub 2006 Aug 17. PMID: 16917002 (Analytic Microscopy Core). Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells. Anticancer Res. 2006 Nov-Dec; 26(6B):4143-8. PMID: 17201125 Gilkes DM, Chen L, Chen J. MDMX regulation of p53 response to ribosomal stress. EMBO J. 2006 Nov 29; 25(23):5614-25. Epub 2006 Nov 16; PMID: 17110929 (Molecular Biology Core). Hu B, Gilkes DM, Farooqi B, Sebti SM, Chen J. MDMX overexpression prevents P53 activation by the MDM2 inhibitor nutlin. J Biol Chem. 2006 Nov 3; 281(44):33030-5. Epub 2006 Aug 11. PMID: 16905541 (Drug Discovery Core and Molecular Biology Core). Wang C, Chen L, Hou X, Li Z, Kabra N, Ma Y, Nemoto S, Finkel T, Gu W, Cress WD, Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol. 2006 Sep; 8(9):1025-31. Epub 2006 Aug 6. PMID: 16892051 (Molecular Biology Core). Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, Sharma A, Simon G. RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non-Small-Cell Lung Cancer. J Clin Oncol. 2006 Sep 11; PMID: 16966686 (Analytic Microscopy Core). Chen L, Sung SS, Yip ML, Lawrence HR, Ren Y, Guida WC, Sebti SM, Lawrence NJ, Wu J. Discovery of a Novel Shp2 Protein Tyrosine Phosphatase Inhibitor. Mol Pharmacol. 2006 Aug; 70(2):562-70. Epub 2006 May 22. PMID: 16717135 (Drug Discovery Core). Rodriguez JM, Glozak MA, Ma Y, Cress WD. Bok, Bcl-2 related ovarian killer, is cell cycle regulated and sensitizes to stress-induced apoptosis. J Biol Chem. 2006 Aug 11; 281(32):22729-35. Epub 2006 Jun 13. PMID: 16772296 (Cress Pilot Project). Jensen EH, McLoughlin JM, Yeatman TJ. Microarrays in gastrointestinal cancer: is personalized prediction of response to chemotherapy at hand? Curr Opin Oncol. 2006 Jul; 18(4):374-80. PMID: 16721134 Zheng Z, Cantor A, Bepler G. A Global Genome Damage Score Predictive of Lung Cancer Patients Outcome. Oncogene. 2006 Jul 27; 25(32):4491-4. Epub 2006 Mar 6. PMID: 16518406 (Bepler Pilot Project). Fiskus W, Pranpat M, Bali P, Balasis M, Kumaraswamy S, Boyapalle S, Rocha K, Wu J, Giles F, Manley PW, Atadja P, Bhalla K. Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl expressing human leukemia cells. Blood. 2006 Jul 15; 108(2):645-52. Epub 2006 Mar 14. PMID: 16537804 (Bhalla Pilot Project). Emmons M, Boulware D, Sullivan DM, Hazlehurst LA. Topoisomerase II beta levels are a determinant of melphalan-induced DNA crosslinks and sensitivity to cell death. Biochem Pharmacol. 2006 Jun 28; 72(1):11-8. Epub 2006 Mar 28. PMID: 16678798 (Biostatistics Core). Zhang L, Yoder SJ, Enkemann SA. Identical probes on different high-density oligonucleotide microarrays can produce different measurements of gene expression. BMC Genomics. 2006 Jun 15; 7:153. PMID: 16776839 (Microarray Core). Vitale L, Lenzi L, Huntsman SA, Canaider S, Frabetti F, Casadei R, Facchin F, Carinci P, Zannotti M, Coppola D, Strippoli P. Differential expression of alternatively spliced mRNA forms of the insulin-like growth factor 1 receptor in human neuroendocrine tumors. Oncol Rep. 2006 May; 15(5):1249-56. PMID: 16596194 (Tissue Procurement Core). Bloomston M, Zhou JX, Rosemurgy AS, Frankel W, Muro-Cacho CA, Yeatman TJ. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res. 2006 Mar 1; 66(5):2592-9. PMID: 16510577 (Analytic Microscopy Core). Donapaty S, Louis S, Horvath E, Kun J, Sebti SM, Malafa MP. RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling. Mol Cancer Ther. 2006 Feb; 5(2):309-16. PMID: 16505104 (Analytic Microscopy Core). Yamaguchi H, Wang HG. Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells. Mol Cell Biol. 2006 Jan; 26(2):569-79. PMID: 16382148 (Drug Discovery Core). Koomen JM, Wilson CR, Guthrie P, Androlewicz MJ, Kobayashi R, Taegtmeyer H. Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J Proteome Res. 2006 Jan; 5(1):177-82. PMID: 16396509 (Proteomics Core). Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res. 2006 Jan 1; 12(1):11-9. PMID: 16397018 (Microarray Core, Analytic Microscopy Core and Biostatistics Core). Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res. 2006 Jan 1; 12(1):20-8. PMID: 16397019 (Tissue Procurement, Analytic Microscopy and Biostatistics Cores).
NFGC - Supported Publications from 2006
Page edited 06/10/09